Pharmaceutical & BioTech

Our services along the whole product lifecycle
Services by stage

Discover all our Market Access services

Drug Development Regulatory Affairs Market Access Pharmacovigilance Quality & Compliance Case Studies

Integrated strategy and execution in the European markets

A TOP-TIER CONSULTING NETWORK

RPN offers a well-coordinated European market access solution through its EU Network of highly-specialized consulting agencies with solid experience in delivering
a winning launch across Europe.

Its goal is to support international and ambitious healthcare clients who expect a fast and successful market access and pricing strategy for the launch of their innovative products in Europe.

SYNERGY FOR HTA REGULATION

Through the EU network, RPN combines in-depth knowledge about European market access requirements as well as about local markets and stakeholders.

Moreover, the new HTA regulation (applicable from January 2025) involves a joint clinical assessment at the European level but maintains pricing and reimbursement negotiations and decisions at national level.
This makes the synergies generated by the EU network of paramount importance.